MPN Congress 2022 | The clinical significance of splenomegaly in polycythemia vera
Ghaith Abu-Zeinah, MD, Weill Cornell Medicine and the New York Presbyterian Hospital, New York City, NY, comments on the results of a study investigating whether splenomegaly correlates with long-term outcomes and survival in patients with polycythemia vera (PV). Dr Abu-Zeinah explains that the study reported that at diagnosis, splenomegaly was predictive of myelofibrosis (MF)-free survival but not overall survival (OS) in patients with PV, explaining how this information can be used to make better treatment decisions. This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
